Loading data
DNLINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0 USD | 0 USD | 330.53 m USD | 105.07 m USD | 48.66 m USD |
| Research and development expense | 418.78 m USD | 396.44 m USD | 423.88 m USD | 358.73 m USD | 265.35 m USD |
| Operating profit | -555.34 m USD | -487.34 m USD | -196.7 m USD | -340.74 m USD | -295.75 m USD |
| Income tax expense | 102 k USD | 68 k USD | 30 k USD | 21 k USD | -575 k USD |
| Net income (reported basis) | -512.54 m USD | -422.77 m USD | -145.22 m USD | -325.99 m USD | -290.58 m USD |
| Basic earnings per share | -2.97 USD/share | -2.57 USD/share | -1.06 USD/share | -2.6 USD/share | -2.39 USD/share |
| Diluted earnings per share | -2.97 USD/share | -2.57 USD/share | -1.06 USD/share | -2.6 USD/share | -2.39 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.